Director of Bioassay Analytics & Development R&D

AbbVie; North Chicago (IL); On-site; USD 161,000 - 305,000; Full time

Job summary

AbbVie, based in North Chicago, seeks an experienced Director to guide Bioassay Analytical Development R&D. You will build and lead a high-impact team of scientists and people leaders, drive strategy for potency assays, and ensure rigorous GMP-compliant development across traditional and novel biologics.

The role demands strong leadership, deep expertise in cell-based and binding assays, and collaboration with global partners to advance programs through clinical development.

Qualifications

• Bachelor’s Degree in Science with extensive related work experience (typically 18 years).
• Master’s Degree or PharmD with extensive related work experience (typically 16 years).
• PhD in Science with at least 10 years of pharma/biotech industry experience.

Responsibilities

• Build and lead a team of up to 10 scientists and people leaders for potency and molecule characterization.
• Provide global interface to structural characterization units to support liabilities and QC attributes.
• Define global development strategy for potency assays across traditional and novel therapies.
• Foster innovative technologies and platformability assessments to streamline testing.
• Oversee GMP-compliant and regulatory affairs, ensuring timely deliverables.
• Mentor NBE talents and manage cross-disciplinary groups across multiple projects.

Skills

Team leadership

Strategic planning

People management

Communication skills

GMP knowledge

Education

Bachelor’s Degree in Science

Master’s Degree in Science or PharmD

PhD in Science

Job description

AbbVie, based in North Chicago, seeks an experienced Director to guide Bioassay Analytical Development R&D. You will build and lead a high-impact team of scientists and people leaders, drive strategy for potency assays, and ensure rigorous GMP-compliant development across traditional and novel biologics.

The role demands strong leadership, deep expertise in cell-based and binding assays, and collaboration with global partners to advance programs through clinical development.